Concepedia

Johan Beetens

JB

Statistics

Publications

24

Citations

940

H-Index

17

Active since

1978

Affiliations

Janssen (Belgium)(Current)

University of Antwerp

Galapagos (Belgium)

Galapagos (France)

Ghent University Hospital

Johan Beetens is an author at Janssen (Belgium) specializing in pharmacology, medicine, and vascular biology.

Top concepts

Publications per year

1978–2022

24

Publications

24

Ketoconazole inhibits the biosynthesis of leukotrienes in vitro and in vivo

Johan Beetens, W. Loots, Yves Somers et al. · Biochemical Pharmacology · 1986 · 142 citations

, , +3

R 68 070: Thromboxane A2 Synthetase Inhibition and Thromboxane A2/Prostaglandin Endoperoxide Receptor Blockade Combined in One Molecule - I. Biochemical Profile In Vitro

Fred De Clerck, Johan Beetens, Didier de Chaffoy de Courcelles et al. · Thrombosis and Haemostasis · 1989 · 105 citations

, , +19

R 68 070: Thromboxane A2 Synthetase Inhibition and Thromboxane A2/Prostaglandin Endoperoxide Receptor Blockade Combined in One Molecule - II. Pharmacological Effects In Vivo and Ex Vivo

Fred De Clerck, Johan Beetens, A. Van de Water et al. · Thrombosis and Haemostasis · 1989 · 88 citations

Blood levels of 6-oxo-prostaglandin F1α during endotoxin-induced hypotension in rabbits

Hidde Bult, Johan Beetens, Arnold G. Herman · European Journal of Pharmacology · 1980 · 54 citations

, , +6

Safety, pharmacokinetics and pharmacodynamics of GLPG0974, a potent and selective FFA2 antagonist, in healthy male subjects

Florence Namour, René Galien, Tim Van Kaem et al. · British Journal of Clinical Pharmacology · 2016 · 53 citations · Full text

Rows per page

1–5 of 24